Sleep Stability Intervention for Type 1 Diabetes
Trial Summary
What is the purpose of this trial?
People with type 1 diabetes are disproportionately affected by cardiovascular disease (CVD). Short and irregular sleep have been associated with cardiovascular risk in this population. Improving sleep regularity has been associated with improved glycemic markers however mechanisms by which improving sleep regularity improves metabolic and cardiovascular health is not known. The investigators propose to conduct a mechanistic study using a sleep stability manipulation. This proposal will advance the understanding of mechanisms by which improving sleep regularity influences glycemic control and cardiovascular risk in T1D.
Research Team
Eligibility Criteria
This trial is for individuals with type 1 diabetes who may be experiencing cardiovascular issues due to irregular or insufficient sleep. The study aims to understand how stabilizing sleep patterns can improve heart health and blood sugar control in these patients.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Sleep stability intervention (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Illinois at Chicago
Lead Sponsor
Mark I. Rosenblatt
University of Illinois at Chicago
Chief Executive Officer
MD, PhD, MBA, MHA
Jon Radosta
University of Illinois at Chicago
Chief Medical Officer since 2023
MD
National Institutes of Health (NIH)
Collaborator
Dr. Jeanne Marrazzo
National Institutes of Health (NIH)
Chief Medical Officer
MD from University of California, Los Angeles
Dr. Jay Bhattacharya
National Institutes of Health (NIH)
Chief Executive Officer
MD, PhD from Stanford University
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Dr. Gary H. Gibbons
National Heart, Lung, and Blood Institute (NHLBI)
Chief Executive Officer since 2012
MD from Harvard Medical School
Dr. James P. Kiley
National Heart, Lung, and Blood Institute (NHLBI)
Chief Medical Officer since 2011
MD from University of California, San Francisco